Summit Therapeutics Inc.
SMMT
$22.69
-$0.65-2.79%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
10/9/2025
-
ETF Channel
10/9/2025
-
Zacks Investment Research
10/9/2025
-
Tickeron - Stocks
10/9/2025
-
MarketBeat
10/8/2025
-
PR Newswire
10/7/2025
-
Zacks Investment Research
10/7/2025
-
Tickeron - Technical Analysis
10/7/2025
-
Insider Monkey
10/7/2025
-
MarketBeat
Summit Therapeutics (SMMT): Valuation Insights Following Disappointing Phase III Ivonescimab Results
10/5/2025
-
Simply Wall St
10/5/2025
-
Fool.com Headlines
10/3/2025
-
PR Newswire
10/3/2025
-
Simply Wall St
10/2/2025
-
Tickeron - Stocks
10/1/2025
-
MarketBeat
9/29/2025
-
Insider Monkey
9/28/2025
-
PR Newswire
9/27/2025
-
Simply Wall St
9/27/2025
-
Tickeron - Stocks
9/25/2025
-
The Fly
9/25/2025
-
Tickeron - Stocks
9/25/2025
-
Tickeron - Stocks
9/24/2025
-
GuruFocus
9/24/2025
-
Globe Newswire
9/24/2025
-
Business Wire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, August 11, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Oct 27 and 31 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
305 203 2034
Address
601 Brickell Key Drive
Miami, FL 33131
Miami, FL 33131
Country
Year Founded
Business Description
Sector
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its...
more